{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T23:20:24Z","timestamp":1787527224635,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-55589-4","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T12:16:31Z","timestamp":1781093791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative prediction of pathological pelvic lymph node metastasis in prostate cancer using an elastic net model integrating clinicopathologic and 68Ga-PSMA PET\/CT features: development and temporal validation"],"prefix":"10.1038","volume":"16","author":[{"given":"Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaonan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"55589_CR1","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.eururo.2024.11.013","volume":"87","author":"EJ Schafer","year":"2025","unstructured":"Schafer, E. J. et al. Recent patterns and trends in global prostate cancer incidence and mortality: An update. Eur. Urol. 87, 302\u2013313 (2025).","journal-title":"Eur. Urol."},{"key":"55589_CR2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.annonc.2020.06.011","volume":"31","author":"C Parker","year":"2020","unstructured":"Parker, C. et al. Prostate cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 31, 1119\u20131134 (2020).","journal-title":"Ann. Oncol."},{"key":"55589_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford, P. et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur. Urol. 86, 148\u2013163 (2024).","journal-title":"Eur. Urol."},{"key":"55589_CR4","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s43018-025-00907-4","volume":"5","author":"Z Wang","year":"2025","unstructured":"Wang, Z. et al. Prostate cancer in China: epidemiological trends, genomic insights, and future directions for optimized management. J. Natl. Cancer Cent. 5, 474\u2013485 (2025).","journal-title":"J. Natl. Cancer Cent."},{"key":"55589_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.euros.2022.07.013","volume":"44","author":"M Perera","year":"2022","unstructured":"Perera, M. & Touijer, K. A. Pelvic lymph node dissection at the time of radical prostatectomy: Extended or not. The referee point of view. Eur. Urol. Open Sci. 44, 24\u201326 (2022).","journal-title":"Eur. Urol. Open Sci."},{"key":"55589_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-024-03344-2","volume":"22","author":"B Dong","year":"2024","unstructured":"Dong, B., Zhan, H., Luan, T. & Wang, J. The role and controversy of pelvic lymph node dissection in prostate cancer treatment: A focused review. World J. Surg. Oncol. 22, 68 (2024).","journal-title":"World J. Surg. Oncol."},{"key":"55589_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.euo.2021.02.001","volume":"4","author":"GE Cacciamani","year":"2021","unstructured":"Cacciamani, G. E. et al. Impact of pelvic lymph node dissection and its extent on perioperative morbidity in patients undergoing radical prostatectomy for prostate cancer: A comprehensive systematic review and meta-analysis. Eur. Urol. Oncol. 4, 134\u2013149 (2021).","journal-title":"Eur. Urol. Oncol."},{"key":"55589_CR8","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3390\/cancers17040655","volume":"17","author":"N Miura","year":"2025","unstructured":"Miura, N. et al. Extended lymph node dissection may not provide a therapeutic benefit in patients with intermediate-to high-risk prostate cancer treated with robotic-assisted radical prostatectomy. Cancers 17, 655 (2025).","journal-title":"Cancers"},{"key":"55589_CR9","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1200\/JCO.22.00645","volume":"40","author":"Y Cao","year":"2022","unstructured":"Cao, Y. & Deville, C. Adjuvant radiation for pathologically node-positive prostate cancer: evidence when early salvage may not be early enough. J. Clin. Oncol. 40, 2179\u20132182 (2022).","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"55589_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.urolonc.2024.12.219","volume":"43","author":"V Jayalath","year":"2025","unstructured":"Jayalath, V. et al. Adjuvant vs. salvage radiotherapy in men with pathologically node positive prostate cancer after radical prostatectomy: A systematic review and meta-analysis. Urol. Oncol. 43, 87 (2025).","journal-title":"Urol. Oncol."},{"key":"55589_CR11","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.eururo.2011.10.044","volume":"61","author":"A Briganti","year":"2012","unstructured":"Briganti, A. et al. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: The essential importance of percentage of positive cores. Eur. Urol. 61, 480\u2013487 (2012).","journal-title":"Eur. Urol."},{"key":"55589_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.euros.2025.06.003","volume":"78","author":"R Zelic","year":"2025","unstructured":"Zelic, R. et al. Adaption of the Memorial Sloan Kettering Cancer Center nomograms for the prediction of prostate cancer-specific death in Sweden: A population-based cohort study. Eur. Urol. Open Sci. 78, 41\u201350 (2025).","journal-title":"Eur. Urol. Open Sci."},{"key":"55589_CR13","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.amjmed.2025.06.002","volume":"138","author":"EJ Goetzl","year":"2025","unstructured":"Goetzl, E. J. & Washington, S. L. Recent advances in diagnosis and treatment of prostate cancer. Am. J. Med. 138, 1497\u20131501 (2025).","journal-title":"Am. J. Med."},{"key":"55589_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61050924","volume":"61","author":"J G\u00f3mez Rivas","year":"2025","unstructured":"G\u00f3mez Rivas, J. et al. Prostate-specific membrane antigen positron emission tomography (PSMA-PET) in initial staging of prostate cancer patients: The beginning of a new era. Medicina (Mex.) 61, 924 (2025).","journal-title":"Medicina (Mex.)"},{"key":"55589_CR15","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","volume":"50","author":"WP Fendler","year":"2023","unstructured":"Fendler, W. P. et al. PSMA PET\/CT: Joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0. Eur. J. Nucl. Med. Mol. Imaging 50, 1466\u20131486 (2023).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"55589_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s43856-022-00180-x","volume":"2","author":"W Qiu","year":"2022","unstructured":"Qiu, W. et al. Interpretable machine learning prediction of all-cause mortality. Commun. Med. 2, 125\u2013140 (2022).","journal-title":"Commun. Med."},{"key":"55589_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/bjc.2014.639","volume":"112","author":"GS Collins","year":"2015","unstructured":"Collins, G. S., Reitsma, J. B., Altman, D. G. & Moons, K. G. M. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Br. J. Cancer. 112, 251\u2013259 (2015).","journal-title":"Br. J. Cancer"},{"key":"55589_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m441","author":"R Riley","year":"2020","unstructured":"Riley, R. et al. Calculating the sample size required for developing a clinical prediction model. BMJ https:\/\/doi.org\/10.1136\/bmj.m441 (2020).","journal-title":"BMJ"},{"key":"55589_CR19","doi-asserted-by":"publisher","DOI":"10.4081\/aiua.2025.13746","author":"P Pepe","year":"2025","unstructured":"Pepe, P., Pepe, L., Cignoli, D. & Roscigno, M. PSMA PET\/CT in the diagnosis of prostate cancer: Why and when?. Arch. Ital. Urol. Androl. https:\/\/doi.org\/10.4081\/aiua.2025.13746 (2025).","journal-title":"Arch. Ital. Urol. Androl."},{"key":"55589_CR20","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.21873\/invivo.13769","volume":"38","author":"P Pepe","year":"2024","unstructured":"Pepe, P. et al. PSMA PET\/CT accuracy in diagnosing prostate cancer nodes metastases. Vivo 38, 2880\u20132885 (2024).","journal-title":"Vivo"},{"key":"55589_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.euo.2023.05.003","volume":"6","author":"G Gandaglia","year":"2023","unstructured":"Gandaglia, G. et al. Identification of the optimal candidates for nodal staging with extended pelvic lymph node dissection among prostate cancer patients who underwent preoperative prostate-specific membrane antigen positron emission tomography. External validation of the memorial sloan kettering cancer center and briganti nomograms and development of a novel tool. Eur. Urol. Oncol. 6, 543\u2013552 (2023).","journal-title":"Eur. Urol. Oncol."},{"key":"55589_CR22","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.eururo.2018.10.012","volume":"75","author":"G Gandaglia","year":"2019","unstructured":"Gandaglia, G. et al. A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies. Eur. Urol. 75, 506\u2013514 (2019).","journal-title":"Eur. Urol."},{"key":"55589_CR23","doi-asserted-by":"publisher","first-page":"1583806","DOI":"10.3389\/fonc.2025.1583806","volume":"15","author":"R Lau","year":"2025","unstructured":"Lau, R. et al. Real world prevalence of pelvic lymph node involvement in prostate cancer in Asia: do we need a rethink on normograms? Front. Oncol. 15, 1583806 (2025).","journal-title":"Front. Oncol."},{"key":"55589_CR24","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1007\/s10147-021-01954-4","volume":"26","author":"E Fukagawa","year":"2021","unstructured":"Fukagawa, E. et al. External validation of the briganti 2019 nomogram to identify candidates for extended pelvic lymph node dissection among patients with high-risk clinically localized prostate cancer. Int. J. Clin. Oncol. 26, 1736\u20131744 (2021).","journal-title":"Int. J. Clin. Oncol."},{"key":"55589_CR25","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.eururo.2017.03.049","volume":"72","author":"G Gandaglia","year":"2017","unstructured":"Gandaglia, G. et al. Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer. Eur. Urol. 72, 632\u2013640 (2017).","journal-title":"Eur. Urol."},{"key":"55589_CR26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2021.05.006","volume":"80","author":"D Meijer","year":"2021","unstructured":"Meijer, D. et al. External validation and addition of prostate-specific membrane antigen positron emission tomography to the most frequently used nomograms for the prediction of pelvic lymph-node metastases: an international multicenter study. Eur. Urol. 80, 234\u2013242 (2021).","journal-title":"Eur. Urol."},{"key":"55589_CR27","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.euo.2018.04.016","volume":"1","author":"TA Hueting","year":"2018","unstructured":"Hueting, T. A. et al. External validation of models predicting the probability of lymph node involvement in prostate cancer patients. Eur. Urol. Oncol. 1, 411\u2013417 (2018).","journal-title":"Eur. Urol. Oncol."},{"key":"55589_CR28","doi-asserted-by":"publisher","first-page":"14797","DOI":"10.4081\/aiua.2026.14797","volume":"98","author":"P Pepe","year":"2026","unstructured":"Pepe, P., Pepe, L., Pepe, G. & Fiorentino, V. PSMA PET\/CT in diagnosing and staging high grade prostate cancer: accuracy and cost-effectiveness. Arch. Ital. Urol. Androl. : Organo Uff [di] Soc. Ital. Ecogr Urol. Nefrol. 98, 14797 (2026).","journal-title":"Arch. Ital. Urol. Androl. : Organo Uff [di] Soc. Ital. Ecogr Urol. Nefrol"},{"key":"55589_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.euo.2023.02.006","volume":"6","author":"A Sabbagh","year":"2023","unstructured":"Sabbagh, A. et al. Development and external validation of a machine learning model for prediction of lymph node metastasis in patients with prostate cancer. Eur. Urol. Oncol. 6, 501\u2013507 (2023).","journal-title":"Eur. Urol. Oncol."},{"key":"55589_CR30","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s41391-023-00704-z","volume":"26","author":"H Wang","year":"2023","unstructured":"Wang, H., Xia, Z., Xu, Y., Sun, J. & Wu, J. The predictive value of machine learning and nomograms for lymph node metastasis of prostate cancer: A systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 26, 602\u2013613 (2023).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"55589_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1\u201322 (2010).","journal-title":"J. Stat. Softw."},{"key":"55589_CR32","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.euo.2023.03.010","volume":"6","author":"AN Vis","year":"2023","unstructured":"Vis, A. N. et al. Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomography. Eur. Urol. Oncol. 6, 553\u2013563 (2023).","journal-title":"Eur. Urol. Oncol."},{"key":"55589_CR33","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1007\/s00259-023-06278-1","volume":"50","author":"UJ Muehlematter","year":"2023","unstructured":"Muehlematter, U. J. et al. Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer. Eur. J. Nucl. Med. Mol. Imaging 50, 3137\u20133146 (2023).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"55589_CR34","first-page":"684","volume":"57","author":"Z Wang","year":"2025","unstructured":"Wang, Z. et al. A preoperative prediction model for pelvic lymph node metastasis in prostate cancer: integrating clinical characteristics and multiparametric MRI. Beijing Xue Xue Bao Yi Xue Ban = J. Peking Univ. Health Sci. 57, 684\u2013691 (2025).","journal-title":"Beijing Xue Xue Bao Yi Xue Ban = J. Peking Univ. Health Sci."},{"key":"55589_CR35","doi-asserted-by":"publisher","first-page":"12132","DOI":"10.4081\/aiua.2024.12132","volume":"96","author":"P Pepe","year":"2024","unstructured":"Pepe, P., Pepe, L., Curduman, M., Pennisi, M. & Fraggetta, F. Ductal prostate cancer staging: role of PSMA PET\/CT. Arch. Ital. Urol. Androl. : Organo Uff [di] Soc. Ital. Ecogr Urol. Nefrol. 96, 12132 (2024).","journal-title":"Arch. Ital. Urol. Androl. : Organo Uff [di] Soc. Ital. Ecogr Urol. Nefrol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55589-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55589-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55589-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T23:11:52Z","timestamp":1787526712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55589-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55589"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55589-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"29 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethics Committee of the First Hospital of Shanxi Medical University (KYLL-2024-265). Given the retrospective analysis of de-identified data, informed consent was waived.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26425"}}